The Anastomosis Devices Market was valued at USD 3.61 billion in 2023 and is projected to reach USD 6.63 billion by 2032, growing at a CAGR of 7.01% from 2024 to 2032. This growth is driven by the rising prevalence of cardiovascular and gastrointestinal disorders, increasing bariatric surgeries due to obesity, and a surge in trauma-related surgical cases worldwide. Advances in surgical technology, such as minimally invasive and robotic-assisted procedures, alongside innovations like magnetic compression and bio absorbable materials, are revolutionizing anastomosis techniques and enhancing patient outcomes.